These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33002236)

  • 1. Comment on "Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling-controlled case study on the efficacy of lipoprotein apheresis".
    Sbrana F; Dal Pino B; Bigazzi F; Sampietro T
    J Clin Apher; 2021 Feb; 36(1):219-220. PubMed ID: 33002236
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.
    Galiano M; Hammersen J; Sauerstein K; Blessing H; Rümmele P; Purbojo A; Schöber M; Moosmann J; Raffelsbauer G; Heibges A; Klingel R
    J Clin Apher; 2020 Jun; 35(3):163-171. PubMed ID: 32163632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The apheresis of low-density lipoproteins in homozygous familial hypercholesterolemia].
    Ros Rahola E
    Med Clin (Barc); 1993 Jan; 100(3):117-8. PubMed ID: 8426494
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia.
    Meier P; Blanc E
    Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830
    [No Abstract]   [Full Text] [Related]  

  • 5. Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19.
    Vuorio A; Raal F; Klingel R; Kovanen PT
    J Clin Lipidol; 2021; 15(2):379-380. PubMed ID: 34099192
    [No Abstract]   [Full Text] [Related]  

  • 6. LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5.
    Stefanutti C; Notarbartolo A; Colloridi V; Nigri A; Vivenzio A; Bertolini S; Bosco G; Berni A; Di Giacomo S; Mazzarella B
    Artif Organs; 1997 Oct; 21(10):1126-7. PubMed ID: 9335372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
    Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
    Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
    Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis.
    Stefanutti C; Morozzi C; Di Giacomo S; Sovrano B; Mesce D; Grossi A
    J Clin Lipidol; 2016; 10(4):782-789. PubMed ID: 27578108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
    Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
    J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein apheresis in homozygous familial hypercholesterolemia.
    Mora C; Teruel JL; Navarro JF
    Am J Cardiol; 2001 Jul; 88(2):202-3. PubMed ID: 11463060
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia.
    Lefort B; Saheb S; Bruckert E; Giraud C; Hequet O; Hankard R
    Atherosclerosis; 2015 Mar; 239(1):158-62. PubMed ID: 25608117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Role of Lipoprotein Apheresis.
    Thompson G; Parhofer KG
    Curr Atheroscler Rep; 2019 May; 21(7):26. PubMed ID: 31041550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis.
    Kroon AA; Swinkels DW; van Dongen PW; Stalenhoef AF
    Metabolism; 1994 Sep; 43(9):1164-70. PubMed ID: 8084291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis.
    Uauy R; Zwiener RJ; Phillips MJ; Petruska ML; Bilheimer DW
    J Pediatr; 1992 Jun; 120(6):892-8. PubMed ID: 1593349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review.
    Luirink IK; Determeijer J; Hutten BA; Wiegman A; Bruckert E; Schmitt CP; Groothoff JW
    J Clin Lipidol; 2019; 13(1):31-39. PubMed ID: 30553758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis.
    Taylan C; Driemeyer J; Schmitt CP; Pape L; Büscher R; Galiano M; König J; Schürfeld C; Spitthöver R; Versen A; Koziolek M; Marsen TA; Stein H; Schaefer JR; Heibges A; Klingel R; Oh J; Weber LT; Klaus G
    Am J Cardiol; 2020 Dec; 136():38-48. PubMed ID: 32946862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.